In an adult with a history of non‑Hodgkin lymphoma who has had three episodes of generalized urticaria over the past three months, each resolving with systemic steroids and currently asymptomatic, what is the appropriate workup and management?

Workup and Management of Recurrent Urticaria in NHL Patient

Start this patient on a standard-dose second-generation H1-antihistamine (e.g., cetirizine 10mg, loratadine 10mg, or fexofenadine 180mg daily) as first-line therapy, while simultaneously pursuing focused workup to exclude NHL relapse/progression and identify potential autoimmune mechanisms. 1

Immediate Workup

Critical First Step: Exclude NHL-Related Disease

Given the NHL history, this is not typical chronic spontaneous urticaria until proven otherwise. The recurrent nature requiring steroids raises concern for paraneoplastic phenomenon 2:

• CBC with differential - look for lymphocytosis, cytopenias, or atypical cells
• LDH and beta-2 microglobulin - markers of lymphoma activity
• CT chest/abdomen/pelvis - assess for lymphadenopathy or organomegaly
• Consider PET scan if any concerning findings or unexplained constitutional symptoms

Critical pitfall: Urticaria can be a presenting sign of lymphoproliferative disorders, and symptoms may improve with treatment of the underlying malignancy 2. Do not assume this is benign chronic urticaria without excluding active lymphoma.

Standard Urticaria Workup (if NHL excluded)

Per current international guidelines 1:

• CBC with differential
• CRP or ESR
• Total IgE level - low levels suggest autoimmune CSU
• IgG anti-thyroid peroxidase (anti-TPO) - elevated with low IgE suggests autoimmune mechanism
• High anti-TPO/total IgE ratio is the best surrogate marker for autoimmune CSU 1

Document disease activity with validated tools (Urticaria Control Test - UCT score).

Management Algorithm

Step 1: Second-Generation H1-Antihistamine (Current Phase)

Since patient is asymptomatic between episodes:

• Start standard-dose daily second-generation antihistamine (cetirizine 10mg, loratadine 10mg, or fexofenadine 180mg)
• Continue for 2-4 weeks
• Avoid first-generation antihistamines due to sedation and anticholinergic effects 1

Step 2: If Inadequate Control (Breakthrough Episodes)

• Increase antihistamine dose up to 4-fold (e.g., cetirizine 40mg daily, fexofenadine 720mg daily) 1
• This is safe and guideline-recommended
• Continue for 2-4 weeks or until next episode

Step 3: If Still Inadequate Control

• Add omalizumab 300mg subcutaneously every 4 weeks 1
• Allow up to 6 months for response
• If insufficient response, can updose to 600mg every 2 weeks (maximum dose)
• Superior risk-benefit profile compared to cyclosporine

Step 4: Refractory Cases Only

• Cyclosporine up to 5mg/kg body weight as third-line 1
• Monitor BP and renal function (BUN, creatinine) every 6 weeks
• Risks include hypertension, renal dysfunction, hirsutism, gingival hypertrophy

Critical Management Points

Regarding Systemic Corticosteroids

Avoid routine use of systemic steroids - while they provided temporary relief in this patient, evidence shows 3:

• Modest benefit (14-15% absolute improvement in moderate responders, only 2.2% in high responders)
• 15% increased risk of adverse events (NNH = 9)
• Not recommended for chronic management 4, 5
• Use only for severe acute flares, short courses

Step-Down Approach

Once complete control achieved (UCT >16) for ≥3 consecutive months 1:

• Reduce antihistamine dose by no more than 1 tablet per month
• If breakthrough symptoms occur, return to last effective dose
• This "as much as needed, as little as possible" approach minimizes treatment burden

Referral to Allergist

Refer to allergy/immunology for:

• Confirmation of diagnosis
• Consideration of autologous serum testing if refractory to antihistamines
• Initiation of omalizumab or cyclosporine
• Assessment for autoimmune vs autoallergic mechanisms

Red Flags Requiring Urgent Reassessment

• Constitutional symptoms (fever, night sweats, weight loss)
• New lymphadenopathy or organomegaly
• Cytopenias or elevated LDH
• Angioedema without urticaria (consider bradykinin-mediated angioedema - antihistamines/steroids ineffective) 4

The NHL history fundamentally changes the approach - this requires malignancy exclusion before accepting a diagnosis of chronic spontaneous urticaria, as treatment of underlying lymphoma may resolve the cutaneous manifestations entirely 2, 6.